C. Libenciuc
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Melanoma and MAPK Pathways 3
- Peroxisome Proliferator-Activated Receptors 2
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Cutaneous Melanoma Detection and Management 2
- Co-authors
- Émilie Routier (7 shared papers)Caroline Robert (7 shared papers)C. Boutros (4 shared papers)Aurélien Marabelle (1 shared paper)Christine Mateus (4 shared papers)Jean‐Charles Soria (1 shared paper)Franck Carbonnel (2 shared papers)Alexander M.M. Eggermont (2 shared papers)
- Journals
- Annals of Oncology (2 papers)Nature Reviews Clinical Oncology (1 paper)Cell Reports (1 paper)Annales de Dermatologie et de Vénéréologie (2 papers)SSRN Electronic Journal (1 paper)
- Partner nations
- FranceUnited States
In The Last Decade
C. Libenciuc
7 papers receiving 936 citations
C. Libenciuc's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 630
- Immunology 313
- Cancer Research 62
- Pulmonary and Respiratory Medicine 101
- Biological Psychiatry 7
Countries citing papers authored by C. Libenciuc
This map shows the geographic impact of C. Libenciuc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Libenciuc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Libenciuc more than expected).
Fields of papers citing papers by C. Libenciuc
This network shows the impact of papers produced by C. Libenciuc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Libenciuc. The network helps show where C. Libenciuc may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Libenciuc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination Hit paper breakdown → | 2016 | 826 |
| 2 | 2020 | 107 | |
| 3 | 2020 | 3 | |
| 4 | 2016 | 2 | |
| 5 | 2016 | 1 | |
| 6 | 2016 | 1 | |
| 7 | 2016 | 1 |
About C. Libenciuc
C. Libenciuc is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Organic Chemistry, having authored 7 papers that have together received 941 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Melanoma and MAPK Pathways (3 papers), CAR-T cell therapy research (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Immunotherapy and Immune Responses (2 papers), Cutaneous Melanoma Detection and Management (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Synthesis of Tetrazole Derivatives (1 paper). The work is most often cited by research in Oncology (630 citations), Immunology (313 citations), Cancer Research (62 citations), Pulmonary and Respiratory Medicine (101 citations) and Biological Psychiatry (7 citations). C. Libenciuc has collaborated with scholars based in France and United States. Frequent co-authors include Émilie Routier, Caroline Robert, C. Boutros, Aurélien Marabelle, Christine Mateus, Jean‐Charles Soria, Franck Carbonnel, Alexander M.M. Eggermont, Matthieu Texier and Ahmad A. Tarhini. Their work appears in journals such as Annals of Oncology, Nature Reviews Clinical Oncology, Cell Reports, Annales de Dermatologie et de Vénéréologie and SSRN Electronic Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.